IRIS
STROMILLO, MARIA LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.680
EU - Europa 5.398
AS - Asia 1.836
SA - Sud America 402
AF - Africa 36
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 6
Totale 14.368
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.635
GB - Regno Unito 1.802
IE - Irlanda 805
CN - Cina 695
IT - Italia 569
SG - Singapore 528
SE - Svezia 440
UA - Ucraina 431
BR - Brasile 370
RU - Federazione Russa 356
FR - Francia 327
DE - Germania 289
HK - Hong Kong 271
FI - Finlandia 142
KR - Corea 104
ES - Italia 58
VN - Vietnam 53
IN - India 49
NL - Olanda 46
BE - Belgio 38
TR - Turchia 36
CA - Canada 27
BD - Bangladesh 17
AT - Austria 16
MK - Macedonia 15
CI - Costa d'Avorio 12
CZ - Repubblica Ceca 10
JP - Giappone 10
PH - Filippine 9
PK - Pakistan 9
ZA - Sudafrica 9
MX - Messico 8
AR - Argentina 7
AU - Australia 7
IL - Israele 7
MA - Marocco 7
GR - Grecia 6
IQ - Iraq 6
JO - Giordania 6
CO - Colombia 5
EC - Ecuador 5
EU - Europa 5
IR - Iran 5
KZ - Kazakistan 5
VE - Venezuela 5
BG - Bulgaria 4
CH - Svizzera 4
CL - Cile 4
HU - Ungheria 4
KE - Kenya 4
PL - Polonia 4
RS - Serbia 4
SA - Arabia Saudita 4
AL - Albania 3
AM - Armenia 3
AZ - Azerbaigian 3
EG - Egitto 3
JM - Giamaica 3
MD - Moldavia 3
NZ - Nuova Zelanda 3
RO - Romania 3
AE - Emirati Arabi Uniti 2
BB - Barbados 2
BO - Bolivia 2
DK - Danimarca 2
EE - Estonia 2
ID - Indonesia 2
LU - Lussemburgo 2
LV - Lettonia 2
PT - Portogallo 2
SI - Slovenia 2
UY - Uruguay 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BH - Bahrain 1
BY - Bielorussia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
FK - Isole Falkland (Malvinas) 1
HN - Honduras 1
HR - Croazia 1
IM - Isola di Man 1
IS - Islanda 1
KW - Kuwait 1
LT - Lituania 1
MN - Mongolia 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
PY - Paraguay 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TN - Tunisia 1
Totale 14.368
Salva come PNG Salva come JPEG
Città #
Southend 1.639
Fairfield 959
Dublin 799
Ashburn 490
Chandler 469
Woodbridge 468
Menlo Park 439
Santa Clara 413
Houston 378
Wilmington 377
Seattle 361
Jacksonville 354
Cambridge 331
Singapore 279
Hong Kong 263
Beijing 200
Siena 175
Princeton 165
Ann Arbor 163
Nanjing 117
Seoul 99
Milan 92
Hefei 69
Helsinki 58
Boardman 54
Málaga 51
San Mateo 51
San Diego 46
New York 45
Dong Ket 40
Florence 37
Nanchang 37
The Dalles 37
Lancaster 36
Shenyang 35
Columbus 33
Los Angeles 32
London 31
Moscow 29
Munich 28
São Paulo 28
Brussels 27
Tianjin 26
Council Bluffs 25
Bengaluru 23
Düsseldorf 23
Rome 23
Norwalk 22
Changsha 19
Hebei 19
Jiaxing 18
Kunming 18
Shanghai 18
Jinan 17
Dearborn 15
Pisa 15
San Francisco 14
Toronto 14
Belo Horizonte 13
Abidjan 12
Fremont 12
Izmir 12
Boston 11
Nuremberg 11
Rio de Janeiro 11
Turku 11
Washington 11
Waanrode 10
Falkenstein 9
Frankfurt am Main 9
Guarulhos 9
Ningbo 9
Phoenix 9
Amsterdam 8
Brasília 8
Chicago 8
Kilburn 8
Sacramento 8
Zhengzhou 8
Brooklyn 7
Campinas 7
Genoa 7
Hangzhou 7
Amman 6
Dallas 6
Lanzhou 6
Renton 6
Skopje 6
Tokyo 6
Torino 6
Vienna 6
Brno 5
Curitiba 5
Lappeenranta 5
Pescara 5
Porto Alegre 5
Redwood City 5
Stockholm 5
Trabzon 5
Venezia 5
Totale 10.471
Salva come PNG Salva come JPEG
Nome #
Development and psychometric properties of a neuropsychological battery for mild cognitive impairment with small vessel disease: The VMCI-tuscany study 250
Appraisal of brain connectivity in radiologically isolated syndrome by modeling imaging measures 245
Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study 234
Mitochondrial dysfunction in hereditary spastic paraparesis with mutations in DDHD1/SPG28 217
Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis 208
Reliability, practice effects, and change indices for Rao's Brief Repeatable Battery. 208
Cortical damage in brains of patients with adult-form of myotonic dystrophy type 1 and no or minimal MRI abnormalities 200
Gray matter atrophy cannot be fully explained by white matter damage in patients with MS 199
Long-term assessment of no evidence of disease activity in relapsing-remitting MS 196
Connectivity-based parcellation of the thalamus in multiple sclerosis and its implications for cognitive impairment: A multicenter study 195
Relevance of brain lesion location to cognition in relapsing multiple sclerosis 190
Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis 189
Clinical Course of Two Italian Siblings with Ataxia-Telangiectasia-Like Disorder. 188
Structural and metabolic damage in brains of patients with SPG11-related spastic paraplegia as detected by quantitative MRI 184
Clinical relevance of brain volume changes in patients with cerebrotendinous xanthomatosis 182
null 182
Cortical lesions in radiologically isolated syndrome. 179
Automated identification of brain new lesions in multiple sclerosis using subtraction images 177
Twelve-year monitoring of a patient with megalencephalic leukoencephalopathy with subcortical cysts 175
Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome 175
Prognostic biomarkers of IFNb therapy in multiple sclerosis patients 175
The Italian Neuroimaging Network Initiative (INNI): enabling the use of advanced MRI techniques in patients with MS 175
Right-to-left shunt in CADASIL patients: prevalence and correlation with clinical and MRI findings 173
Assessing response to interferon-β in a multicenter dataset of patients with MS 172
Peak width of skeletonized mean diffusivity (PSMD) as marker of widespread white matter tissue damage in multiple sclerosis 172
Cardiac autonomic nervous system and risk of arrhythmias in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). 171
Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis. 168
Brain metabolism changes after therapy with chenodeoxycholic acid in a case of cerebrotendinous xanthomatosis. 168
Pronounced structural and functional damage in early adult pediatric-onset multiple sclerosis with no or minimal clinical disability 168
Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis. 167
Scoring treatment response in patients with relapsing multiple sclerosis 166
Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis 165
Cognitive reserve and cortical atrophy in multiple sclerosis: A longitudinal study 164
Regional cortical thinning in multiple sclerosis and its relation with cognitive impairment: A multicenter study 162
Increased QT variability in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. 161
Deep gray matter volume loss drives disability worsening in multiple sclerosis 160
Peripheral neuropathy in vanishing white matter disease with a novel EIF2B5 mutation 159
Association of MRI metrics and cognitive impairment in radiologically isolated syndromes 157
Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis 156
COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context 155
Rapidly progressive neurodegeneration in a case with the 7472insC mutation and the A7472C polymorphism in the mtDNA tRNA ser(UCN) gene. 153
Leukoencephalopathy as a rare complication of hepatitis C infection. 151
MR evidence of structural and metabolic changes in brains of patients with Werner’s syndrome. 151
Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis. 151
Pronounced focal and diffuse brain damage predicts short-term disease evolution in patients with clinically isolated syndrome suggestive of multiple sclerosis 150
Diffuse structural and metabolic brain changes in Fabry disease 150
Disease modifying therapies and Covid‐19 severity in Multiple Sclerosis 150
Impaired vasoreactivity in mildly disabled CADASIL patients 149
Cortical functional reorganisation and its relationship with brain structural damage in patients with benign multiple sclerosis 148
Prominent brain axonal damage and functional reorganization in "pure" adrenomyeloneuropathy. 147
The Cerebral Autosomal-Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) Scale: A Screening Tool to Select Patients for NOTCH3 Gene Analysis. 147
Post-stroke depression: Research methodology of a large multicentre observational study (DESTRO) 146
Subclinical motor impairment assessed with an engineered glove correlates with magnetic resonance imaging tissue damage in radiologically isolated syndrome 146
Refining response to treatment as defined by the Modified Rio Score 145
Reduced dynamics of functional connectivity and cognitive impairment in multiple sclerosis 145
Improving the characterization of radiologically isolated syndrome suggestive of multiple sclerosis. 142
Natalizumab may reduce cognitive changes and brain atrophy rate in relapsing-remitting multiple sclerosis: a prospective, non-randomized pilot study 136
Modelling the distribution of cortical lesions in multiple sclerosis 136
Diffuse metabolic changes in the brain of patients with familial amyloid polyneuropathy. A proton MRSI study. 134
Effects of Sapropterin on Endothelium-Dependent Vasodilation in Patients With CADASIL: A Randomized Controlled Trial 133
Retinal nerve fibre layer thickness, lesional load and brain atrophy in patients with cerebral autosomal dominant arteriopathy with subcortical infarct and leucoencephalopathy (CADASIL) 133
Isoprostanes in clinically isolated syndrome and early multiple sclerosis as biomarkers of tissue damage and predictors of clinical course 131
APOE-{varepsilon}4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis. 129
Magnetic resonance spectroscopy as a measure of brain damage in multiple sclerosis. 127
The dilemma of benign multiple sclerosis: Can we predict the risk of losing the “benign status”? A 12-year follow-up study 127
A comparison of cognitive performances between multiple sclerosis patients with pediatric- versus adult onset disease 124
Leukoencephalopathy, cerebral calcifications, and parenchimal cysts in two siblings. 124
Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies 123
Structural and Metabolic Brain Abnormalities in Preclinical Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarct and Leukoencephalopathy 119
Dynamics of pseudo-atrophy in RRMS reveals predominant gray matter compartmentalization 119
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study 119
Imaging brain damage in first-degree relatives of sporadic and familial multiple sclerosis 117
null 117
Structural MRI correlates of cognitive impairment in patients with multiple sclerosis: A Multicenter Study 114
Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies 114
Imaging neuronal and axonal degeneration in multiple sclerosis. 113
null 108
Mapping the progressive treatment-related reduction of Active MRI lesions in multiple sclerosis 106
Peak width of skeletonized mean diffusivity (PSMD) and cognitive functions in relapsing-remitting multiple sclerosis 104
Novel human pathological mutations. Gene symbol: NOTCH3. Disease: CADASIL, exon 2 mutation. 102
null 102
MRI quality control for the Italian Neuroimaging Network Initiative: moving towards big data in multiple sclerosis 101
Short-Term Combination of Glatiramer Acetate with IV Steroid Treatment Preceding Treatment with GA Alone Is Associated with early Suppression of MRI-disease activity in Patients with Relapsing Remitting Multiple Sclerosis 100
Cladribine vs other drugs in MS: Merging randomized trial with real-life data 98
Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy 96
DMTs and Covid-19 severity in MS: a pooled analysis from Italy and France 94
null 84
Relevance of hypointense brain MRI lesions for long-term worsening of clinical disability in relapsing multiple sclerosis 83
Efficacy and safety of intravenous immunoglobulin treatment in refractory Behcet's Disease with different organ involvement: a case series 83
Mild gray matter atrophy in patients with long-standing multiple sclerosis and favorable clinical course 83
Longitudinal Assessment of Multiple Sclerosis with the Brain-Age Paradigm 81
Vitamin D levels in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) 77
Antibody response elicited by the SARS-CoV-2 vaccine booster in patients with multiple sclerosis: Who gains from it? 75
Operationalizing mild cognitive impairment criteria in small vessel disease: The VMCI-Tuscany Study 71
The brief repeatable battery of neuropsychological tests (BRB-N) version a: update of Italian normative data from the Italian Neuroimaging Network Initiative (INNI) 71
Resting-state functional MRI in multicenter studies on multiple sclerosis: a report on raw data quality and functional connectivity features from the Italian Neuroimaging Network Initiative 70
Regional hippocampal atrophy reflects memory impairment in patients with early relapsing remitting multiple sclerosis 66
Multicenter data harmonization for regional brain atrophy and application in multiple sclerosis 65
Signs and symptoms of Covid‐19 in patients with multiple sclerosis 64
Effect of BDNF Val66Met polymorphism on hippocampal subfields in multiple sclerosis patients 63
Totale 14.194
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.967
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.967
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.952 72 189 39 132 89 175 231 358 178 163 177 149
2021/20221.441 107 148 99 101 110 70 79 50 79 124 205 269
2022/20231.778 111 151 235 225 160 336 51 155 204 67 53 30
2023/20241.202 61 25 110 48 35 331 429 26 6 25 24 82
2024/20252.931 71 125 240 148 388 164 129 197 230 148 311 780
2025/2026305 305 0 0 0 0 0 0 0 0 0 0 0
Totale 14.634